Lola Weiss
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.
Journal: Haematologica
Published: November 04, 2025
Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1.
Journal: Frontiers in immunology
Published: September 26, 2024
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression.
Journal: Journal of hematology & oncology
Published: June 06, 2022
Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response.
Journal: Journal of hematology & oncology
Published: July 27, 2020
The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.
Journal: Biochemical pharmacology
Published: May 14, 2019
Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.
Journal: Frontiers in immunology
Published: August 02, 2017
CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.
Journal: Cancer research
Published: February 13, 2017
The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 01, 2015
Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes.
Journal: PloS one
Published: August 10, 2014
Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 03, 2013
Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria.
Journal: PloS one
Published: November 28, 2012
Last Updated: 09/26/2026